Tirzepatide Coupon and Savings Card: Who Qualifies and What Else Works

FormBlends Editorial Research. Last reviewed September 9, 2026 against the Zepbound and Mounjaro prescribing information and the trial publications listed under Sources.

The main tirzepatide coupon is Eli Lilly's Zepbound savings card, which can bring the cost down to as little as $25 a month if you have commercial insurance that covers Zepbound. If your plan does not cover it, the card does not help, and your options are Lilly's self-pay vials at $299 to $699 a month or compounded tirzepatide, which at FormBlends is $149 for the first month and $239 after. Start with our tirzepatide guide if you are new to the drug.

Key takeaways

• The Zepbound savings card is a manufacturer program for people with commercial insurance that covers Zepbound; with it, some people pay as little as $25 a month.
• There is no coupon that works without coverage. Without insurance, Lilly's published self-pay prices for Zepbound vials are $299 (2.5 mg), $399 (5 mg), $499 (7.5 mg) and $699 (10, 12.5 and 15 mg) a month.
• FormBlends compounded tirzepatide is $149 for the first month, then $239 a month, or $214 with Subscribe & Save, at any dose, with no coupon code needed.
• Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.
• Eli Lilly sets and changes the savings card rules, so confirm the current terms before you count on them.

What the tirzepatide savings card is

A manufacturer savings card is not a discount on the list price. It is a copay-assistance program: when your insurance covers the drug, the card pays part of your share, so your out-of-pocket cost drops. For Zepbound, Eli Lilly's program can bring the monthly cost to as little as $25 for people whose commercial insurance covers the drug. The exact amount you pay depends on your plan's copay or coinsurance and on the card's monthly maximum benefit, which Lilly sets.

Because it works through insurance, the card cannot create coverage. If your plan excludes weight-loss drugs, or excludes Zepbound specifically, the card has nothing to apply to. That is the most common reason people find the "coupon" does not work.

Who qualifies for the Zepbound savings card

Eligibility rules are set by Eli Lilly and can change, so the list below is the general shape, not a substitute for the current terms.

• You have commercial (private or employer) insurance, and it covers Zepbound for your prescription.
• You have a valid prescription for the drug's labeled use. The Zepbound label covers chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition, and moderate to severe obstructive sleep apnea in adults with obesity.
• Manufacturer copay programs are generally not available to people whose prescriptions are paid by government programs such as Medicare or Medicaid. Check the card terms for the current exclusions.

Mounjaro has its own savings program for its labeled use in type 2 diabetes. The two cards are separate because the two products are approved for different conditions.

Tirzepatide cost by option

Here is every price we can verify, side by side. The table uses Lilly's published LillyDirect self-pay prices for Zepbound vials (accessed September 4, 2026) and FormBlends' pricing block (verified September 5, 2026).

Source: Eli Lilly LillyDirect self-pay pricing (accessed September 4, 2026); FormBlends pricing page (verified September 5, 2026).

Two patterns stand out. Zepbound self-pay gets more expensive as your dose goes up, and the label calls 2.5 mg a starting dose rather than a maintenance dose, so ongoing treatment is at 5 mg or higher. FormBlends' price is flat across doses, so the gap widens as you move up the schedule. Lab work is not included in either.

Is there a tirzepatide coupon code?

Not in the sense of a code you type at checkout. The savings card is an enrollment, not a code. Sites that promise a "tirzepatide coupon code" are usually either pharmacy discount cards, which apply to the cash price at retail pharmacies and vary by pharmacy, or affiliate pages for telehealth services. FormBlends does not use coupon codes; the $149 first month is the price for everyone, and the Subscribe & Save rate is applied automatically to renewals as a flat $25 credit.

How to check whether your insurance covers Zepbound

1. Call the member services number on your insurance card and ask whether Zepbound is on your plan's formulary for your diagnosis, and whether prior authorization is required.
2. Ask what your copay or coinsurance would be. That is the number the savings card reduces.
3. If it is covered, enroll in Lilly's savings program and bring the card to the pharmacy with your prescription.
4. If it is not covered, ask whether your plan has an appeal process. If you have obstructive sleep apnea, ask whether your plan treats that indication differently; your prescriber can advise on whether it applies to you.

The coverage walkthrough video embedded on this page covers those phone calls in more detail.

Alternatives when the savings card does not apply

• LillyDirect self-pay vials. The FDA-approved product at Lilly's published cash prices, $299 to $699 a month by dose. No insurance is involved.
• Compounded tirzepatide. Prescribed by a licensed clinician and prepared by a state-licensed 503A compounding pharmacy. At FormBlends, $149 for the first month and $239 after, at any dose. It is not FDA approved and not interchangeable with Zepbound; a clinician decides whether it is appropriate for you. Our compounded tirzepatide vs Mounjaro comparison lays out the differences.
• Compounded semaglutide. A different GLP-1 drug, at FormBlends $99 for the first month and $190 after, or $165 with Subscribe & Save. In SURMOUNT-5, tirzepatide produced more weight loss than semaglutide (-20.2% versus -13.7% at 72 weeks), so this is a cost trade-off to discuss with a prescriber.

The full breakdown is in our tirzepatide cost guide, and the cost calculator lets you compare plans over a year.

What this means for compounded tirzepatide

If the savings card works for you, use it: Zepbound at $25 a month is the FDA-approved product at the lowest price available. If it does not, compounded tirzepatide is the lower-cost route, with the trade-off that it is not FDA approved. FormBlends pricing is on the pricing page, and the assessment confirms availability for your address before any charge; if the clinician does not prescribe, the charge is refunded.

Frequently Asked Questions

Is there a tirzepatide coupon?

The closest thing is the Zepbound savings card from Eli Lilly, which can lower the cost to as little as $25 a month for people with commercial insurance that covers Zepbound. It is not a coupon for the cash price and does not work without coverage.

How does the tirzepatide savings card work?

You enroll with Lilly, present the card at the pharmacy with your prescription, and it pays part of your insurance copay up to a monthly maximum that Lilly sets. Your plan must already cover Zepbound for it to apply.

Is there a tirzepatide discount card without insurance?

The manufacturer card requires commercial coverage. Without insurance, the published options are Lilly's self-pay Zepbound vials at $299 to $699 a month, or compounded tirzepatide such as FormBlends at $149 for the first month and $239 after, which is not FDA approved.

Is there a tirzepatide coupon code for FormBlends?

No code is needed. The first month is $149 for everyone, ongoing months are $239, and Subscribe & Save renewals bill the plan price minus a flat $25 credit automatically.

What is the tirzepatide discount for Mounjaro?

Mounjaro has a separate Lilly savings program for its labeled use in type 2 diabetes. We do not print its terms here because the only brand price in our verified sources is Zepbound's; check Lilly's current Mounjaro program details directly.

Sources

1. Zepbound prescribing information, DailyMed, revised 08/2026.
2. Mounjaro prescribing information, DailyMed, revised 08/2026.
3. FDA Approves New Medication for Chronic Weight Management, U.S. Food and Drug Administration, November 8, 2023.
4. FDA Approves First Medication for Obstructive Sleep Apnea, U.S. Food and Drug Administration, December 20, 2024.
5. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5), Aronne et al., New England Journal of Medicine, 2025.
6. FormBlends pricing, Form Blends LLC, verified September 5, 2026.

Next steps

If you are starting from zero, read the compounded tirzepatide guide. Browse the tirzepatide hub for every other tirzepatide question. Talk to a licensed clinician before starting or changing any medication. Compounded tirzepatide is not FDA approved and is not interchangeable with Zepbound or Mounjaro; a licensed provider decides whether it is appropriate for you.